- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02416817
Strategy of Transfusion in Trauma Patients - STATA Trial (STATA)
Clinical Trial: Evaluation of 2 Different Protocols of Blood Derivates Transfusion in Acute Trauma Patients in a Brazilian Tertiary Hospital
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this randomized trial trauma patients in need of massive transfusion will be assigned to one of the following transfusion strategies:
- - Fresh Frozen Plasma, Platelets Concentrate and Packed red blood cells in 1:1:1 ratio.
- - These patients will receive Red blood cells based on Haemoglobin measurements and will receive either Beriplex® P/N (CSL Behring GmbH, Marburg, Germany) or Haemocomplettan® P (CSL Behring, Marburg, Germany), or Platelets based on thromboelastometry.
To be included patients must meet the following inclusion criteria:
- - Trauma victims
- - Adults between 18 - 80 years old
- - Injury Severity Score (ISS) between 15 and 45
- - Assessment of Blood Consumption (ABC) Score ≥ 3 points
- - Shock Index ≥ 1,2
- - Acute hemorrhage of more than 50% estimated blood volume in 3 hours or more than 1,5 ml/kg/min of blood during 20 minutes.
Exclusion Criteria:
- - Early cardiac arrest
- - Pregnancy
- - Injury Severity Score (ISS) > 45
- - Patient transferred from another hospital
- - Drug abuse history
- - Known coagulation impairment
- - Known use of anticoagulants, or platelet antiaggregants.
The group of health-care providers recruiting the patients based on eligibility criteria, is different than the group that evaluates the clinical outcomes of the included patients, in such a way that no researcher is tasked with post-randomisation care of the subjects. This is done to prevent observational bias.
Two informed consent forms are signed for each patient. The first one is signed by an independent physician. Another consent form is signed by the patient's family or the own patient within 24 hours of hospital admission.
The randomisation is performed by sealed envelopes assigned to the eligible patients anytime they reach the protocol criteria. The envelopes were created using a computer generated randomisation table specifically designed to this study.
An interim analysis was performed in October 2015 and it showed that there was no increased mortality or morbidity within the intervention group.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
SP
-
Sao Paulo, SP, Brazil, 05403-000
- Hospital das Clinicas FMUSP
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Trauma victims
- Adults between 18 - 80 years old
- Injury Severity Score (ISS) between 15 and 45
- Assessment of Blood Consumption (ABC) Score ≥ 3 points
- Shock Index ≥ 1,2
Exclusion Criteria:
- Early cardiac arrest
- Pregnancy
- ISS > 45
- Patient transferred from another hospital
- Drug abuse history
- Known coagulation impairment
- Known use of anticoagulants, or platelet anti-aggregants. -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Blood Products only.
This arm will receive 1:1:1 Red blood cells : Fresh Frozen Plasma : Platelets upon a major trauma triggers.
1:1:1 Ratio for packs of blood products.
The patient will be re-evaluated every hour again for the major bleeding triggers and another 1:1:1 intervention may or may not occur.
|
Based solely on massive transfusion triggers Patients with traumatic hemorrhage that fulfil the inclusion criteria will receive blood products by prescription of the patient's anesthesiologist.
The patient will be constantly observed and bleeding triggers will be reassessed hourly.
Other Names:
|
Experimental: Point of care guided
This arm will receive Red blood cells, Human Fibrinogen and Prothrombinic complex concentrates (PCC) based on thromboelastometry.
The dosis of each drug will be determined by the analyses of the thromboelastometry curves.
|
Based on massive transfusion triggers and thromboelastometry Patients with traumatic hemorrhage that fulfil the inclusion criteria will receive the drugs guided by the results of the thromboelastometry.
The dosis of each drug will be based on the analysis of the thromboelastometry curves (established algorithm).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SOFA Score - 5 days
Time Frame: 5 days
|
Evaluation of the SOFA score along the first 5 days after the patient admission.
|
5 days
|
Collaborators and Investigators
Investigators
- Study Director: Roseny R Rodrigues, M.D., Hospital das Clínicas HC-FMUSP
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STATA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wounds and Injuries
-
3MWithdrawn
-
Centre Hospitalier Universitaire de NīmesCompletedWounds and Injuries, Hands | Wounds and Injuries, Wrists | Wounds and Injuries, Feet | Wounds and Injuries, AnklesFrance
-
Samsung Medical CenterCompletedNeedle Stick InjuriesKorea, Republic of
-
Assaf-Harofeh Medical CenterUnknownInjuries and Wounds
-
Karolinska InstitutetCompletedWounds and Injuries | Blast Injuries | War-Related Injuries | Gunshot WoundSweden
-
Medical University of South CarolinaCompletedNeedlestick InjuriesUnited States
-
Hospital Universiti Sains MalaysiaActive, not recruiting
-
Temple UniversityWithdrawnLacerations | Injuries | WoundsUnited States
-
Nemera La VerpilliereCompleted
Clinical Trials on Blood Products only
-
Cook Group IncorporatedTerminated
-
Assiut UniversityNot yet recruitingMassive Blood Transfusion in Trauma Patients
-
University of AarhusOdense University Hospital; Norwegian Air Ambulance Foundation; Copenhagen University...RecruitingHemorrhage | Blood Component TransfusionDenmark
-
Indiana UniversityAtlanta Medical CenterCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
The University of Texas Health Science Center,...U.S. Army Medical Research and Development CommandCompletedTrauma/Injury ProblemUnited States
-
Etablissement Français du SangAssistance Publique Hopitaux De Marseille; Centre Hospitalier Universitaire... and other collaboratorsCompletedHematologic Diseases | Trauma | Surgical Blood Loss | Blood Product Transfusion for All Conditions
-
Direction Centrale du Service de Santé des ArméesFloralis; TIMC-IMAGRecruitingTrauma | Coagulopathy | Acute HemorrhageFrance
-
University of Modena and Reggio EmiliaCompletedLiver Cirrhosis | Coagulation Disorder
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingSeminoma | Germ Cell Tumor | Metachronous Malignant Neoplasm | Stage I Testicular Cancer AJCC v8 | Stage IA Testicular Cancer AJCC v8 | Stage IB Testicular Cancer AJCC v8 | Stage IS Testicular Cancer AJCC v8Canada, United States, Guam